Member Exclusive News Drug approvals

The week in industry: FDA approved use of AbbVie’s SKYRIZI™ for psoriasis

Eli Lilly sells rights to two antibiotics and manufacturing facility in China, ACD Therapeutics and Adagene set to collaborate to develop next-generation masked antibody drug conjugates and a new cGMP plasmid manufacturing facility to be launched

Please sign in or register for FREE

No comments yet.